Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications /von 2016-06-09 / Expert Opin Biol Ther 2016 09;16(9):1113-23Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-67Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-11-16 / Cancer Immunol. Immunother. 2012 Jun;61(6):865-79Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-04-01 / Immunotherapy 2011 Apr;3(4):569-76Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2009-06-01 / Scand. J. Immunol. 2009 Jun;69(6):529-36Vaccine therapy and chronic lymphocytic leukaemia
/in Chronic Leukemia, International Publications /von 2008-09-01 / Best Pract Res Clin Haematol 2008 Sep;21(3):421-36Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia
/in Chronic Leukemia, International Publications /von 2008-07-29 / Cancer Immunol. Immunother. 2008 Nov;57(11):1705-10Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
/in Chronic Leukemia, International Publications /von 2008-04-21 / J. Leukoc. Biol. 2008 Jul;84(1):319-25Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
/in Chronic Leukemia, International Publications /von 2008-03-06 / Leukemia 2008 May;22(5):1007-17
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de